Mastodon

Medecins sans Frontieres

Médecins Sans Frontières (MSF) is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare. MSF offers assistance to people based on need, irrespective of race, religion, gender or political affiliation. Our actions are guided by medical ethics and the principles of neutrality and impartiality. www.msf.org

Gaza, MSF: “Hospitals overloaded, medical supplies almost exhausted and limited access to drinking water”

15 October 2023 – In the north of the Gaza Strip the situation is dramatic, hospitals are overloaded and drugs and painkillers are running out. The wounded scream in pain, while those who need treatment are unable to reach hospitals…

DRC, MSF: “Humanitarian catastrophe in North Kivu, urgent response needed”

A humanitarian catastrophe is unfolding in North Kivu, in the east of the Democratic Republic of Congo (DRC), where an estimated 1 million people have been forced to flee their homes in the past 12 months to escape fighting related…

MSF humanitarian convoy enters Syria

Feb. 19, 2023 – A Médecins Sans Frontières (Doctors Without Borders) (MSF) humanitarian convoy of 14 trucks (see photo) entered northwestern Syria today from Turkiye through the Hammam border crossing. This first convoy is carrying 1,296 tents for families (of…

MSF welcomes EU pharmaceutical strategy but challenges key intellectual property issue

Geneva, 25 November 2020 – MSF’s Access Campaign welcomes the European Commission’s (EC)pharmaceutical strategy for Europe and its objective on improving access to affordable medicines and medical tools through increased transparency and a review of its intellectual property (IP) incentives…

MSF supports India and South Africa ask to waive COVID-19 patent rights

In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) related to COVID-19 drugs, vaccines, diagnostics and other technologies for the duration of the…